Single-Photon Emission Computed Tomography (SPECT) is a nuclear medicine imaging technique primarily used to assess functional abnormalities and blood flow in human organs. After injecting a radioactive isotope, the device captures differences in tissue absorption of radiation to generate three-dimensional images, assisting physicians in diagnosing diseases of the heart, brain, and bones. Unlike CT or MRI, SPECT's advantage lies in displaying organ metabolic activity and blood flow dynamics, often used in conjunction with anatomical imaging techniques.
This technology is particularly sensitive to functional lesions in clinical applications, such as early detection of myocardial ischemia or localization of epileptic foci in the brain. The examination duration ranges from approximately 30 minutes to several hours, depending on the area examined and the type of radiotracer used. The entire process is painless and non-invasive.
SPECT mainly includes cardiac SPECT, brain SPECT, and skeletal SPECT. Its mechanism involves injecting a radioactive isotope (e.g., Technetium-99m) intravenously, after which different tissues absorb varying amounts of imaging agents based on metabolic activity or blood flow differences. The detector rotates around the patient, capturing gamma rays emitted by the isotope, and reconstructs a three-dimensional image via computer, revealing abnormal regions of organ function distribution.
Compared to Positron Emission Tomography (PET), SPECT uses isotopes with shorter half-lives and lower costs but has slightly lower spatial resolution. This characteristic makes it the standard examination for assessing blood flow dynamics (such as myocardial perfusion), especially in outpatient settings.
In cardiology, indications include evaluating myocardial ischemia in angina patients, monitoring treatment effects of coronary artery disease, and ruling out diagnoses in patients with acute chest pain. In neurology, it is used for localizing seizure sources, early screening for Alzheimer's disease, and assessing cerebral blood flow abnormalities post-stroke.
In the skeletal system, applications include staging primary or metastatic bone tumors, localizing causes of unexplained bone pain, and evaluating inflammatory activity in rheumatoid arthritis. Additionally, it can analyze glomerular filtration and blood flow distribution in kidney diseases.
Fasting for 4-6 hours before the exam is recommended, and patients should inform their doctor if pregnant or breastfeeding. The dose of the radiotracer depends on the area examined; for example, cardiac SPECT typically uses about 7-11 mCi of Technetium-99m Tc-sestamibi, with a total absorbed dose lower than standard X-ray examinations. Patients should lie still and remain immobile for 15-60 minutes; in special cases, pharmacologic stress testing (such as adenosine injection) may be used to induce myocardial ischemia.
Dosage calculations follow the ALARA (As Low As Reasonably Achievable) principle, with adjustments made for children or patients undergoing repeated scans. Post-examination, drinking plenty of water is advised to accelerate radiotracer elimination, which is usually fully metabolized within 24-48 hours.
In terms of cost-effectiveness, SPECT has lower operational costs compared to PET scans and offers unique advantages in diagnosing cardiac and neurological diseases, often serving as an initial outpatient screening tool.
The primary risk is radiation exposure; however, the total dose from a single scan is equivalent to background radiation received over 3-6 months in the natural environment. A small number of patients may experience allergic reactions to the radiotracer, such as rash or difficulty breathing, which requires allergy history assessment before the procedure.
Special risk groups: Pregnant women should avoid the procedure strictly due to potential fetal effects; patients with thyroid disease need dose adjustments when using iodine-containing radiotracers; patients with severe renal impairment may have prolonged metabolism of radioactive substances, increasing tissue accumulation risks.
Within 24 hours after the scan, avoid close contact with pregnant women or infants. Clothing should be washed to remove residual radioactivity.
SPECT itself does not directly interact chemically with medications, but attention should be paid to timing between radiotracer and other drugs: for example, diuretics may accelerate the elimination of radioactive substances, affecting image quality; diabetic patients injecting glucose-based tracers may experience altered results.
In treatment planning, SPECT results are often combined with decisions on coronary angioplasty or preoperative brain localization. Patients should inform their healthcare providers of all medications they are taking.
In cardiology, multicenter studies show SPECT has a diagnostic accuracy of 89% for myocardial ischemia, outperforming the 65% accuracy of electrocardiograms. A 2018 JAMA study indicated that combining SPECT with CT fusion imaging increased sensitivity for tumor metastasis detection by 30%.
In epilepsy assessment, SPECT combined with EEG improves lesion localization accuracy and is a standard preoperative evaluation for epilepsy surgery. Long-term follow-up studies demonstrate that SPECT-guided treatment plans can reduce misdiagnosis rates by 30%.
If patients are contraindicated for radiation exposure, alternatives include:
• Cardiac ultrasound: no radiation but limited in functional assessment
• Tumor-targeted ultrasound: insufficient resolution for deep lesions
• Brain PET: higher resolution but more costly
If radiation exposure is to be avoided, CT perfusion imaging or MRI functional imaging can be alternatives, though they are less specific for functional assessment compared to SPECT. The choice depends on lesion depth, organ metabolic characteristics, and available medical resources.
It is recommended to avoid iodine-containing foods or drinks, such as seafood and iodized salt, 24 hours before the scan. If taking potassium or calcium supplements, inform medical staff in advance to adjust timing. On the day of the exam, wear comfortable clothing and avoid wearing metal jewelry to prevent interference with image quality.
Can I move or ventilate if I feel anxious or dizzy during the procedure?The scanner space is relatively small and enclosed. If feeling unwell, notify staff immediately via the built-in intercom. Although the scan lasts about 30-60 minutes, adjustments or pauses can be made as needed. Medical staff will assess whether additional ventilation or short breaks are necessary. Please communicate your needs proactively.
Do I need to adjust my medication after the scan?If using radioactive tracers, drinking plenty of water within 24 hours post-scan is recommended to accelerate metabolism. Usually, routine medications do not need to be stopped. Patients undergoing kidney or liver treatments should follow medical advice, monitor urine color changes, and report any abnormal symptoms such as persistent nausea or difficulty urinating within 24 hours.
How do I interpret abnormal results, and when is immediate treatment necessary?Abnormal reports are categorized into "urgent follow-up" and "regular observation." If there is significant blood flow deficiency or abnormal metabolic accumulation, physicians will recommend secondary examinations such as angiography or tissue biopsy based on medical history and symptoms. Patients should bring all previous examination reports to assist in evaluating trends.
How soon can I resume normal activities after a SPECT scan?Normal diet and light activities can be resumed immediately after the scan. However, it is advised to avoid driving or operating delicate machinery for the rest of the day. For scans involving the heart or brain, strenuous exercise should be avoided for 24 hours, and any symptoms like dizziness or muscle soreness should be monitored. It is recommended to discuss the results and next steps with your physician within 72 hours.
%201.svg)
Copyright © 2025 MedFrontiers. All Rights Reserved.
